SarcoSIGHT
SarcoSIGHT: A Randomised-Control Trial of Fluorescence Guided Sarcoma Surgery Versus the Standard of Care
- Study stage: Set-up
- Sponsor: The Newcastle Upon Tyne Hospitals NHS Foundation Trust
- Funder: National Institute for Health and Care Research (NIHR) Efficacy and Mechanism Evaluation (EME) Programme
- Therapeutic area: Cancer and Neoplasm
- Type of study: Surgical
Aim: To determine whether FGS using ICG reduces the UPM rate compared to the current standard of care (SoC).
Primary Outcome: The UPM rate, defined as the percentage of patients with an unexpected positive margin, will be compared between the two treatment arms.
- Population: Adult
- Design: RCT (open label)
- Setting: Secondary Care
- Planned Sample Size: 500